** Cannabis firms rise in afternoon trading following a media report that said U.S. is set to reclassify marijuana
** U.S. administration is expected to announce the move as soon as Wednesday, Axios reports, citing an official familiar with the matter
** Cronos Group CRON.TO and Aurora Cannabis ACB.TO rise 8.5% and 9%, respectively
** Tilray Brands TLRY.TO jumps over 12% and Canopy Growth WEED.TO surges 16.7%
** ETF AdvisorShares Pure US Cannabis MSOS.P up 16.3%
** The decision to reclassify cannabis as a less dangerous drug does not legalize cannabis, but eases the operating environment for companies by improving access to capital, reducing tax burden and accelerating research and development
** Currently, marijuana, along with LSD and heroin, is a Schedule I controlled substance, meaning it has no accepted medical use and a high potential for abuse
(Reporting by Mrinalika Roy)